MarketCap
Facebook
X
Telegram
Country |
 Irlanda |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
19.7 M |
Market Cap[1] |
$ 591 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Novavax
NVAX
|
$ 11.26 | 1.42 % | $ 1.82 B | Nasdaq Global Select Market |  USA |
 |
Novo Nordisk A/S
NVO
|
$ 38.83 | 0.14 % | $ 173 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 150.62 | 0.16 % | $ 292 B | NYSE |  Schweiz |
 |
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 9.18 | 2.64 % | $ 115 M | Nasdaq Global Select Market,SPB | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.87 | 2.5 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.58 | 1.03 % | $ 572 M | Nasdaq Global Select Market | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.51 | 0.72 % | $ 2.22 B | Nasdaq Global Market |  Canada |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.32 | 0.11 % | $ 352 M | Nasdaq Global Select Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 157.14 | 0.08 % | $ 7.82 B | Nasdaq Global Market,SPB | USA |
 |
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.07 | 0.97 % | $ 169 M | Nasdaq Global Select Market |  Israel |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.87 | 0.53 % | $ 52.2 M | Nasdaq Capital Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.15 | 3.2 % | $ 280 M | Nasdaq Global Select Market | USA |
 |
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | USA |
 |
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | USA |
|
Foghorn Therapeutics
FHTX
|
$ 1.85 | 2.16 % | $ 117 M | Nasdaq Global Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.62 | 0.27 % | $ 231 M | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.92 | 0.01 % | $ 6.13 M | Nasdaq Global Select Market | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 7.79 | 0.19 % | $ 1.64 B | Nasdaq Global Select Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 9.83 | 3.14 % | $ 492 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 63.62 | 0.67 % | $ 8.66 B | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.01 | 8.87 % | $ 4.96 B | Nasdaq Capital Market | Israel |
 |
Pharming Group N.V.
PHAR
|
$ 9.36 | 0.42 % | $ 6.45 B | Nasdaq Global Select Market |  Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 6.92 | 1.35 % | $ 505 M | Nasdaq Global Select Market,SPB | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.9 | 10.01 % | $ 55.2 M | Nasdaq Global Select Market | USA |
 |
Equillium
EQ
|
$ 1.19 | 0.38 % | $ 68.2 M | Nasdaq Global Market | USA |
 |
GeoVax Labs
GOVX
|
$ 0.24 | 6.84 % | $ 230 K | Nasdaq Global Select Market | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.78 | 3.32 % | $ 505 K | Nasdaq Capital Market | Israel |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
Prothena Corporation plc
PRTA
|
$ 8.35 | 1.18 % | $ 449 M | Nasdaq Global Select Market,SPB | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 13.07 | 1.32 % | $ 10.9 B | NYSE |  India |
 |
Replimune Group
REPL
|
$ 10.86 | 3.16 % | $ 1.01 B | Nasdaq Global Select Market | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 45.97 | 0.92 % | $ 827 M | Nasdaq Global Select Market | USA |
 |
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | USA |
 |
Geron Corporation
GERN
|
$ 1.17 | 3.36 % | $ 780 M | Nasdaq Global Select Market | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.79 | 2.87 % | $ 14.3 M | NYSE American,SPB | USA |
 |
Gilead Sciences
GILD
|
$ 156.19 | 2.49 % | $ 194 B | Nasdaq Global Select Market,SPB | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 14.05 | 0.79 % | $ 12.1 B | Nasdaq Global Select Market |  China |
 |
Entera Bio Ltd.
ENTX
|
$ 2.68 | 10.8 % | $ 124 M | Nasdaq Capital Market | Israel |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 64.25 | 0.72 % | $ 179 M | Nasdaq Global Select Market | Israel |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.